MIDAZOLAM HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Midazolam Hydrochloride patents expire, and when can generic versions of Midazolam Hydrochloride launch?
Midazolam Hydrochloride is a drug marketed by Apothecon, Baxter Hlthcare Corp, Bedford, Ben Venue, Epic Pharma Llc, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Hospira Inc, Igi Labs Inc, Intl Medicated, Intl Medication, Micro Labs, Pai Holdings, Rising, Akorn, Padagis Us, Pharm Assoc, Sun Pharm Inds Ltd, Rafa Labs Ltd, and Steriscience. and is included in thirty-six NDAs.
The generic ingredient in MIDAZOLAM HYDROCHLORIDE is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midazolam Hydrochloride
A generic version of MIDAZOLAM HYDROCHLORIDE was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
Summary for MIDAZOLAM HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 22 |
NDAs: | 36 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Clinical Trials: | 1,455 |
Patent Applications: | 1,090 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in MIDAZOLAM HYDROCHLORIDE? | MIDAZOLAM HYDROCHLORIDE excipients list |
DailyMed Link: | MIDAZOLAM HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MIDAZOLAM HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nova Scotia Health Authority | Phase 3 |
Abraham Nunes | Phase 3 |
National Trauma Center | N/A |
Pharmacology for MIDAZOLAM HYDROCHLORIDE
Drug Class | Benzodiazepine |